Anybody who loves the game hates the fact that steroids became so
pervasive in the sport, but for a 20-year period, I think most of the
elite players were using performance-enhancing drugs, and within the
context of that time — when baseball wasn’t doing anything to stop the
growth of drug use — this was what the sport was. And we don’t know
exactly who did what . . . I think in order to have a consistent standard when considering the
steroid-era players, you either have to vote for no one at all, or set
aside the steroid issue and just vote for the best players of the era.
— Buster Olney, explaining why he voted for Mark McGwire for the Hall of Fame and why he will vote for him and for Barry Bonds, Roger Clemens and Alex Rodriguez when they come on the ballot.
Unless the writers who think differently either (a) explain their clairvoyance in knowing who did and who didn’t do steroids; or (b) admit that they are totally fine with voting for steroid users who managed not to get caught, I can’t see how they can approach the matter any other way.
Jon Morosi of MLB Network and FOX Sports reports that the Mariners have acquired starter Chris Heston from the Giants. The Giants will receive a player to be named later, per Jon Heyman of FanRag Sports.
Heston, 28, logged only five innings in the majors this past season as he battled an oblique injury and otherwise spent most of his time with Triple-A Sacramento. Heston was solid out of the Giants’ rotation in 2015, posting a 3.95 ERA with a 141/64 K/BB ratio in 177 2/3 innings over 31 starts.
Heston will be under team control through 2021. He’ll provide depth for the Mariners’ rotation in the meantime.
Joe Nathan‘s agent, David Pepe, says his client wants to pitch in 2017, per ESPN’s Jerry Crasnick. “He’s like the Energizer Bunny,” Pepe said.
Nathan, 42, came back from Tommy John surgery in July, pitching two scoreless innings for the Cubs with four strikeouts and two walks. The Cubs released him and the Giants picked him up, and Nathan went on to pitch 4 1/3 scoreless innings down the stretch with five strikeouts and two walks.
According to FanGraphs, Nathan’s velocity wasn’t where it used to be, which is to be expected of a pitcher in his 40’s coming back from major elbow surgery. Still, with teams always on the hunt for bullpen depth, it would be shocking if Nathan didn’t get any bites before spring training starts.